Bio Decontamination equipment and Sterilisation Services Since 1987
LAF technologies offers Tomi SteraMist™ BIT™ Solution Ionized Hydrogen Peroxide (IHP) and Phileas Devea H202 Hydrogen Peroxide technologies. The BIO-Decontamination systems are used for critical applications in the Bio Security, Healthcare, Life Science, research, IVF, food and pharmaceutical industries.
Airborne disinfection is a widely used method utilised throughout the world, including Australia. Examples of such technologies include hydrogen peroxide vapour, hydrogen peroxide fogging and ultra-violet light.
TOMI Environmental Solutions, Inc SteraMist™ BIT™ Solution airborne disinfection systems are USA EPA approved for Room Sterilization by Fogger Application For use as a Healthcare-Hospital Disinfectant. Microbial Disinfection, Fogging, Misting, aerosolised spray. 7.8% Hydrogen Peroxide.
Devea Phileas O2 Safe® 7.4% Hydrogen Peroxide airborne disinfection systems meet the French standard NFT 72 281 : 2014 Methods of airborne disinfection of surfaces – determination of bactericidal, fungicidal, yeasticidal, mycobactericidal, tuberculocidal sporicidal and virucidal activity, including bacteriophages.
Laftech provides on-site biological decontamination and sterilisation services Utilising proprietary technologies to a variety of industries including Bio Security, Life Sciences, Pharmaceutical, Food & Beverage, Healthcare, Emergency Services, and Transportation.
Our highly effective, proven technologies guarantee repeatable efficacies provide decontamination services for contaminated zones, rooms and equipment for emergency outbreak control or routine maintenance tailored to your specific needs. We have been performing routine decontaminations services into many of Australia’s leading State Bio Security Quarantine facilities and leading pharmaceutical clean room facilities.
Validated, automated decontamination services for ‘six-log’ 99.9999% efficacy of enveloped viruses
Do not confuse with manually operated ‘fogging’ systems which offer much lower efficacy rates